pubmed-article:8633212 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8633212 | lifeskim:mentions | umls-concept:C0017355 | lld:lifeskim |
pubmed-article:8633212 | lifeskim:mentions | umls-concept:C0034678 | lld:lifeskim |
pubmed-article:8633212 | lifeskim:mentions | umls-concept:C0013081 | lld:lifeskim |
pubmed-article:8633212 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
pubmed-article:8633212 | lifeskim:mentions | umls-concept:C0439064 | lld:lifeskim |
pubmed-article:8633212 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:8633212 | pubmed:dateCreated | 1996-6-28 | lld:pubmed |
pubmed-article:8633212 | pubmed:abstractText | A number of tumours and oncogene transformed cells displayed reduced MHC class I surface expression which seemed to enable their escape from immune surveillance. To test whether oncogenic activation is directly involved in suppressing MHC class I expression, a model of inducible oncogene expression was chosen. Mouse fibroblasts transfected with different oncogenes expressed under the control of the dexamethasone-inducible MMTV promoter were analysed in the presence and absence of hormone for the mRNA and protein expression of MHC class I molecules as well as the respective oncogenes. Immunofluorescence analyses demonstrated an inverse association of MHC class I and oncogene expression after dexamethasone stimulation, independent of the type of oncogene causing transformation. Hormone-mediated induction of oncogene expression caused down-regulation of all H-2 loci. Kinetic experiments using MMTV c-Ha-ras(A) transfectants revealed that down-regulation of MHC class I surface expression was preceded by a dexamethasone-induced change of morphology, anchorage-independent growth, and an increase of the ras protein p 21. Parallel monitoring of mRNA expression demonstrated a time-dependent up-regulation of ras specific transcripts, which was associated with differential regulation of MHC class I heavy and light chain transcripts. Beta2-microglobulin transcripts were transiently suppressed, whereas MHC class I heavy chain transcripts remained unaffected. To investigate the mechanisms of oncogene-mediated down-regulation of MHC class I expression, H-2 promoter transfections and a nuclear run on assays were performed. In MMTV c-Ha-ras(A) cells, neither alterations of the H-2 promoter activity nor of the transcriptional activity of H-2 antigens was observed in the presence of dexamethasone, whereas both could be up-regulated by interferon-gamma treatment. These data suggest that oncogene-mediated transformation is directly associated with MHC class I down-regulation, but that complex interactions affecting MHC class I heavy and light chain genes at the transcriptional and/or post-transcriptional level are involved in this process. | lld:pubmed |
pubmed-article:8633212 | pubmed:language | eng | lld:pubmed |
pubmed-article:8633212 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8633212 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:8633212 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8633212 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8633212 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8633212 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8633212 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8633212 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8633212 | pubmed:month | May | lld:pubmed |
pubmed-article:8633212 | pubmed:issn | 0300-9475 | lld:pubmed |
pubmed-article:8633212 | pubmed:author | pubmed-author:HuberCC | lld:pubmed |
pubmed-article:8633212 | pubmed:author | pubmed-author:LohmannSS | lld:pubmed |
pubmed-article:8633212 | pubmed:author | pubmed-author:SeligerBB | lld:pubmed |
pubmed-article:8633212 | pubmed:author | pubmed-author:WollscheidUU | lld:pubmed |
pubmed-article:8633212 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8633212 | pubmed:volume | 43 | lld:pubmed |
pubmed-article:8633212 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8633212 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8633212 | pubmed:pagination | 537-44 | lld:pubmed |
pubmed-article:8633212 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
pubmed-article:8633212 | pubmed:meshHeading | pubmed-meshheading:8633212-... | lld:pubmed |
pubmed-article:8633212 | pubmed:meshHeading | pubmed-meshheading:8633212-... | lld:pubmed |
pubmed-article:8633212 | pubmed:meshHeading | pubmed-meshheading:8633212-... | lld:pubmed |
pubmed-article:8633212 | pubmed:meshHeading | pubmed-meshheading:8633212-... | lld:pubmed |
pubmed-article:8633212 | pubmed:meshHeading | pubmed-meshheading:8633212-... | lld:pubmed |
pubmed-article:8633212 | pubmed:meshHeading | pubmed-meshheading:8633212-... | lld:pubmed |
pubmed-article:8633212 | pubmed:meshHeading | pubmed-meshheading:8633212-... | lld:pubmed |
pubmed-article:8633212 | pubmed:meshHeading | pubmed-meshheading:8633212-... | lld:pubmed |
pubmed-article:8633212 | pubmed:meshHeading | pubmed-meshheading:8633212-... | lld:pubmed |
pubmed-article:8633212 | pubmed:meshHeading | pubmed-meshheading:8633212-... | lld:pubmed |
pubmed-article:8633212 | pubmed:meshHeading | pubmed-meshheading:8633212-... | lld:pubmed |
pubmed-article:8633212 | pubmed:meshHeading | pubmed-meshheading:8633212-... | lld:pubmed |
pubmed-article:8633212 | pubmed:meshHeading | pubmed-meshheading:8633212-... | lld:pubmed |
pubmed-article:8633212 | pubmed:meshHeading | pubmed-meshheading:8633212-... | lld:pubmed |
pubmed-article:8633212 | pubmed:meshHeading | pubmed-meshheading:8633212-... | lld:pubmed |
pubmed-article:8633212 | pubmed:meshHeading | pubmed-meshheading:8633212-... | lld:pubmed |
pubmed-article:8633212 | pubmed:year | 1996 | lld:pubmed |
pubmed-article:8633212 | pubmed:articleTitle | Multiple levels of MHC class I down-regulation by ras oncogenes. | lld:pubmed |
pubmed-article:8633212 | pubmed:affiliation | Johannes Gutenberg-University, Third Department of Internal Medicine, Mainz, Germany. | lld:pubmed |
pubmed-article:8633212 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:8633212 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8633212 | lld:pubmed |